SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-292683
Filing Date
2020-11-13
Accepted
2020-11-13 13:19:59
Documents
3
Period of Report
2020-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d42965d8k.htm 8-K 18021
2 EX-99.1 d42965dex991.htm EX-99.1 73098
3 GRAPHIC g42965g80g98.jpg GRAPHIC 4759
  Complete submission text file 0001193125-20-292683.txt   98943
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 201310468
SIC: 2834 Pharmaceutical Preparations